- Datametrex will be providing the 1copy™ COVID-19 qPCR Multi Kit to test crew members, onboard performers, technicians and stagehands
- The testing will commence September 30th continuing into the first quarter of 2022
- Datametrex AI Limited is a technology-focused company
- Datametrex AI Limited (DM) opened trading at C$0.175 per share
Datametrex (DM) has entered into a COVID-19 testing service agreement for a cruise line operated by one of the world’s largest entertainment companies.
Datametrex will be providing the 1copy™ COVID-19 qPCR Multi Kit, that can identify the new variants of COVID-19, for use in testing officers, crew performers, directors, choreographers, audio technicians, stagehands, and costume technicians at the Toronto area rehearsal facility.
The testing will commence September 30th continuing into the first quarter of 2022 and will increase each month until the full entertainment operations are hired and trained.
Marshall Gunter, CEO of Datametrex commented on the agreement.
“This new testing service for the cruise industry gets our feet in a new revenue stream. When the pandemic hit in March 2020, cruise ships were particularly hit hard, which brought the industry to a halt worldwide stranding over 50 cruise lines and more than 270 ships. In an industry worth approximately $150 billion, and 1,177,000 jobs equaling $50.24 billion in wages and salaries, it is important to test crew regularly to minimize the threat of a shutdown again.”
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.
Datametrex AI Limited (DM) opened trading at C$0.175 per share.
